Spasmium Comp 500mg/ml+4mg/ml Solution for injection 100ml

   Product Ref: CHSPA01 Category: S

52.30


Vat Rate: 20%

Prescription Required



Horses, cattle, pigs, dogs: Treatment of spasms or sustained increased tonus of smooth muscles of the gastro-intestinal tract or of the urine and bile excretory organs associated with pain. Horses only: Spasmodic colics. Cattle, pigs, dogs only: As supportive therapy for acute diarrhoea.
Vat Rate: 20%

Royal Mail 2nd Class / Parcel Force 48

UK to UK :Normally arrives in 2-4 business days.

UK to Ireland :Normally arrives in 4-6 business days

UK to EU Countries : Normally arrives in 6-10 working days depending on where the parcel is going

 

Please note standered delivery is none trackable , none insured , no responsabily for lose or Damage

 

----------------------------------------------------------------------------------------------------------------

 

Royal Mail First Class / Parcel Force 24

UK to UK :Normally arrives in 1-2 business days.

UK to Ireland 3-4 business days

UK to EU Countries : Normally arrives in 6-10 working days depending on where the parcel is going

 

Please note :Trackable , Royal Mail insured up to £50.

 

--------------------------------------------------------------------------------------------------------

Parcel Force Express AM Guaranteed before Midday.

UK to UK only . UP to 5KG Max Weight

Arrives next day before 12 noon, requires a signature.

 

Parcel Forcel Terms & Conditions apply

 

Important: Parcel Force advise that there are some postcodes where an extended delivery time exists, and may affect the date of delivery or the service is not available.

 

You must be logged in to write review
Category POM-V
Temperature Ambient
MA/VM/EU No: 22080/4007
Species
  • cattle
  • dog
  • horse
  • pig
VMD Link Product Information Database (defra.gov.uk)
NOAH Link https://www.noahcompendium.co.uk/?id=-463782
Dosage Horse, cattle: intravenous use Pig: intramuscular use Dog: intravenous or intramuscular use Dosage instruction: Horse: 25 mg metamizole sodium monohydrate/kg body weight and 0.2 mg hyoscine butylbromide/kg body weight (i.e. 2.5 ml per 50 kg) Cattle: 40 mg metamizole sodium monohydrate/kg body weight and 0.32 mg hyoscine butylbromide/ kg body weight (i.e. 4 ml per 50 kg) Calf: 50 mg metamizole sodium monohydrate/kg body weight and 0.4 mg hyoscine butylbromide/kg body weight (i.e. 1 ml per 10 kg) Pig: 50 mg metamizole sodium monohydrate/kg body weight and 0.4 mg hyoscine butylbromide/kg body weight (i.e. 1 ml per 10 kg) Dog: 50 mg metamizole sodium monohydrate/kg body weight and 0.4 mg hyoscine butylbromide/kg body weight (i.e. 0.1 ml per kg) Treatment frequency: Cattle and calves: up to twice daily for three days. Horses and pigs: single injection. Dogs: single injection. Treatment can be repeated after 24 hours if necessary. The stopper must not be punctured more than 25 times. Contra-indications Do not use in cases of hypersensitivity to the active substances or to any of the excipients. Do not use in cases of: - gastro-intestinal ulceration - chronic gastro-intestinal disorders - mechanic stenoses in the gastro-intestinal system - paralytic ileus in horses - disorders of the haematopoietic system - blood clotting disorders - renal insuciency - tachyarrhythmia - glaucoma - prostate adenoma. Adverse reactions In horses and cattle, a slight increase in heart rate may be observed occasionally due to the inhibitory eect of hyoscine butylbromide on the parasympathetic system. In dogs painful reactions at the injection site can occur immediately after injection, which abate rapidly and have no negative impact on the expected therapeutic benefit. In very rare cases, anaphylactic reactions may occur and should be treated symptomatically. If you notice any serious effects or other effects not mentioned in this datasheet, please inform your veterinary surgeon. Special precautions for use in animals Due to the risk of anaphylactic shock metamizole-containing solutions should be administered slowly when given intravenously. Special precautions to be taken by the person administering the veterinary medicinal product to animals In a very small number of people, metamizole can cause reversible, but potentially serious agranulocytosis and other reactions such as skin allergy. Take care to avoid self-injection. In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. People with known hypersensitivity to metamizole or hyoscine butylbromide should avoid contact with the veterinary medicinal product. Avoid use of the product if you are known to be sensitive to pyrazolones, or are sensitive to acetylsalicylic acid. Wash splashes from skin and eyes immediately. Use during pregnancy and lactation Studies in laboratory animals (rabbit, rat) have not produced any evidence of a toxic effect on reproduction. No information on use during pregnancy in the target species is available. An effect upon the smooth muscles of the birth canal can occur. Metabolites of metamizole cross the placental barrier and penetrate into milk. Therefore this product should be used only according to the benefit-risk assessment by the responsible veterinarian. Interaction with other medicinal products and other forms of interaction The effects of metamizole and/or hyoscine butylbromide may be potentiated by concurrent use of other anticholinergic or analgesic substances. Concomitant use of inducers of hepatic microsomal enzymes (e.g. barbiturates, phenylbutazone) reduces the half-life period and hence the duration of action of metamizole. Simultaneous administration of neuroleptics, especially phenothiazine derivatives, may lead to severe hypothermia. Furthermore the risk of gastro-intestinal bleeding is increased upon concurrent use of glucocorticoids. The diuretic effect of furosemide is attenuated. Co-administration of other weak analgesics increases the effects and side-effects of metamizole. The anticholinergic action of chinidin and antihistaminics as well as the tachycardic effects of β-sympathomimetics may be enhanced by this veterinary medicinal product. Overdose (symptoms, emergency procedures, antidotes) The acute toxicity of both active substances is very low. In studies with rats the symptoms were non-specific and included: ataxia, dilation of pupils, increased heart rate, exhaustion, convulsions, unconsciousness and respiratory signs. In case of overdosage treatment should be discontinued. Physostigmin is recommended as an antidote to hyoscine butylbromide. A specific antidote for metamizole sodium is not available. Therefore symptomatic treatment should be initiated in case of overdosage. Due to the inhibitory effect of hyoscine butylbromide on the parasympathetic system a slight increase in the heart rate was observed in some cases in horses and cattle following administration of the double therapeutic dose. Incompatibilities In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.
Withdrawals Meat and offal: Horse, cattle (IV) 12 days Pig (IM) 15 days Milk: Cattle (IV) 4 days Do not use in mares whose milk is intended for human consumption.